SE435515B - Sett att framstella 11beta-substituerade 4,9-diensteroidderivat - Google Patents

Sett att framstella 11beta-substituerade 4,9-diensteroidderivat

Info

Publication number
SE435515B
SE435515B SE7714613A SE7714613A SE435515B SE 435515 B SE435515 B SE 435515B SE 7714613 A SE7714613 A SE 7714613A SE 7714613 A SE7714613 A SE 7714613A SE 435515 B SE435515 B SE 435515B
Authority
SE
Sweden
Prior art keywords
group
compounds
methyl
formula
hydroxy
Prior art date
Application number
SE7714613A
Other languages
English (en)
Swedish (sv)
Other versions
SE7714613L (sv
Inventor
J G Teutsch
D Philibert
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7714613L publication Critical patent/SE7714613L/
Publication of SE435515B publication Critical patent/SE435515B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7714613A 1977-01-13 1977-12-21 Sett att framstella 11beta-substituerade 4,9-diensteroidderivat SE435515B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7700858A FR2377418A1 (fr) 1977-01-13 1977-01-13 Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
SE7714613L SE7714613L (sv) 1978-07-14
SE435515B true SE435515B (sv) 1984-10-01

Family

ID=9185437

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714613A SE435515B (sv) 1977-01-13 1977-12-21 Sett att framstella 11beta-substituerade 4,9-diensteroidderivat

Country Status (14)

Country Link
US (1) US4233296A (no)
JP (1) JPS5392752A (no)
BE (1) BE862869A (no)
CA (1) CA1115266A (no)
CH (1) CH633811A5 (no)
DE (2) DE2858797C2 (no)
DK (1) DK161333C (no)
FR (1) FR2377418A1 (no)
GB (1) GB1595132A (no)
HU (1) HU176006B (no)
IE (1) IE46301B1 (no)
LU (1) LU78861A1 (no)
NL (1) NL7800363A (no)
SE (1) SE435515B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801452C2 (de) * 1978-01-13 1985-03-28 Agfa-Gevaert Ag, 5090 Leverkusen Magnetisches Aufzeichnungsmaterial
FR2495621A1 (fr) * 1980-12-05 1982-06-11 Roussel Uclaf Nouveaux derives de l'estra 4,9-diene, leur procede de preparation et leur application comme medicaments
FR2625505B2 (fr) * 1981-01-09 1991-05-10 Roussel Uclaf Nouveaux derives steroides substitues en 11beta leur procede de preparation et leur application comme medicaments et les compositions pharmaceutiques les renfermant
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US5182381A (en) * 1982-03-01 1993-01-26 Roussel Ulcaf Intermediates for 3-keto-19-nor-Δ4,9 -steroids
FR2639045B2 (fr) * 1982-03-01 1994-07-29 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
DE3231827A1 (de) * 1982-08-24 1984-03-01 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3410880A1 (de) 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
DE3438500C1 (de) * 1984-10-18 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung 11ß-substituierter Δ↑9↑-19-Norsteroide
DE3504421A1 (de) * 1985-02-07 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
FR2598421B1 (fr) * 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
US4861763A (en) * 1986-09-17 1989-08-29 Research Triangle Institute 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5272140A (en) * 1987-01-23 1993-12-21 Akzo N.V. 11-aryl steroid derivatives
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
JPH02188599A (ja) * 1988-11-16 1990-07-24 Roussel Uclaf ３―ケト―デルタ―４，９―１９―ノルステロイドから誘導される新物質及びそれらよりなる薬剤
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
US5581233A (en) * 1995-06-06 1996-12-03 Barr; William A. Vehicle door lock, shift lever interlock system
FR2826004B1 (fr) * 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
EP2550288A1 (en) * 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
BR112014029131B1 (pt) 2012-05-31 2021-03-09 Allergan Pharmaceuticals International Limited cápsula de mucoadesivo
CA2888377C (en) 2012-11-02 2021-02-02 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
HU230397B1 (hu) * 2013-11-25 2016-04-28 Richter Gedeon Nyrt. Eljárás (11b,17a)-17-acetoxi-11-metil-19-norpregn-4-én-3,20-dion előállítására

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3527778A (en) * 1969-02-27 1970-09-08 Searle & Co 3,17 - bisoxygenated 11betamethyl - 19 - norpregn - 4 - en - 20 - ones and derivatives thereof
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
FR2235949B1 (no) * 1973-06-18 1978-03-17 Roussel Uclaf
FR2237906A1 (en) * 1973-06-26 1975-02-14 Roussel Uclaf 11-oxo estr-9-ene derivs. - intermediates in the synthesis of steroids
US3978048A (en) * 1973-07-13 1976-08-31 Sandoz, Inc. 17β-SUBSTITUTED-ALLENE-BEARING STEROIDS

Also Published As

Publication number Publication date
LU78861A1 (fr) 1978-09-18
DK161333C (da) 1991-12-09
IE780078L (en) 1978-07-13
DE2858797C2 (no) 1993-06-03
SE7714613L (sv) 1978-07-14
DK161333B (da) 1991-06-24
FR2377418A1 (fr) 1978-08-11
FR2377418B1 (no) 1979-04-20
JPS5392752A (en) 1978-08-15
JPS6247878B2 (no) 1987-10-09
CA1115266A (fr) 1981-12-29
DE2801416A1 (de) 1978-07-20
IE46301B1 (en) 1983-04-20
GB1595132A (en) 1981-08-05
CH633811A5 (fr) 1982-12-31
DE2801416C2 (no) 1992-09-17
HU176006B (en) 1980-11-28
US4233296A (en) 1980-11-11
NL7800363A (nl) 1978-07-17
DK13878A (da) 1978-07-14
BE862869A (fr) 1978-07-12

Similar Documents

Publication Publication Date Title
SE435515B (sv) Sett att framstella 11beta-substituerade 4,9-diensteroidderivat
CA2170286C (en) Synthesis of 17-(3-pyridyl) steroids
CN105669811A (zh) 新的7-酮-6β-烷基胆烷酸衍生物在制备奥贝胆酸以及其在医药领域的用途
JPS58201800A (ja) ３―ケト―δ↑４‖↑９―１９―ノルステロイドの新誘導体、それらの製造法及びそれらを含む製薬組成物
JP5417562B2 (ja) 抗プロゲステロン剤としての１７−α−置換−１１−β−置換−４−アリールおよび２１−置換１９−ノルプレグナジエンジオン
TW548277B (en) Orally active androgens
PT94462A (pt) Processo para a preparacao de 11b-aril-4-estrenos e de composicoes farmaceuticas que os contem
FI94349B (fi) Menetelmä terapeuttisesti aktiivisten 11 -fenyyli-4,9,15-estratrieenien valmistamiseksi
CA2516319A1 (en) Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
PT86591B (pt) Processo para a preparacao de 11beta-alcinil-estrenos e de 11beta-alcinil-estradienos e de composicoes farmaceuticas que os contem
JP3202224B2 (ja) １１β―アリール―ゴナ―４，９―ジエン―３―オン、その製造方法及びそれを含有する調剤学的調製剤
SE435516B (sv) Sett att framstella nya 11beta-substituerade 1,3,5(10)-triensteroidderivat
PT85395B (pt) Processo de preparacao de 18- fenilesteroides e de composicoes farmaceuticas que os contem
RU2125575C1 (ru) СПОСОБ ПОЛУЧЕНИЯ 16α-МЕТИЛИРОВАННЫХ СТЕРОИДОВ, СОЕДИНЕНИЯ
HU194276B (en) Process for producing new steroides substituted with groups containing double- or triple bond at the 10 position and pharmaceutical compositions containing them
JPS5959700A (ja) １１β−アリ−ル−１７α−アルキニル−１７β−ヒドロキシ−４，９（１０）エストラジエン−３−オン誘導体、その製法及び該誘導体を含有する抗ゲスタゲン作用を有する製薬的調剤
JP2999258B2 (ja) １０β―Ｈ―ステロイドの製法
US5502223A (en) Process for preparation of Δ4,9(11),16 pregnatriene-3,20-diones
GB2098614A (en) Corticoid synthesis via new steroid 17-allene 21-sulfoxides
DK164324B (da) 11beta-substituerede 5-hydroxy-9-en-steroidforbindelser til anvendelse som udgangsmaterialer ved fremstilling af 11beta-substituerede 4,9-diensteroidforbindelser samt fremgangsmaade til fremstilling af disse udgangsmaterialer
US4031074A (en) Process for the preparation of 11β-hydroxy-18-alkyl-estrane compounds
Peterson et al. Solvents of low nucleophilicity. XV. Effects of substituents at C-17 upon the rates of solvolysis of 3-tosyloxy steroids
JPS6360035B2 (no)
US5650526A (en) Process for the preparation of an oxoetiocholenic acid
Schwede et al. Synthesis and biological activity of 17-chloro-16 (17) unsaturated D-homo antiprogestins

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7714613-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7714613-2

Format of ref document f/p: F